Proteolysis of β-dystroglycan in muscular diseases
- 1 May 2005
- journal article
- research article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 15 (5) , 336-341
- https://doi.org/10.1016/j.nmd.2005.01.007
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Molecular Recognition by LARGE Is Essential for Expression of Functional DystroglycanCell, 2004
- ZZ domain is essentially required for the physiological binding of dystrophin and utrophin to -dystroglycanHuman Molecular Genetics, 2004
- Disruption of dystroglycan axis by β-dystroglycan processing in cardiomyopathic hamster muscleNeuromuscular Disorders, 2003
- Glycosylation defects: a new mechanism for muscular dystrophy?Human Molecular Genetics, 2003
- Protein glycosylation in disease: new insights into the congenital muscular dystrophiesTrends in Pharmacological Sciences, 2003
- Post-translational disruption of dystroglycan–ligand interactions in congenital muscular dystrophiesNature, 2002
- Structural and Functional Analysis of the N-Terminal Extracellular Region of β-DystroglycanBiochemical and Biophysical Research Communications, 1999
- Dystroglycan: an extracellular matrix receptor linked to the cytoskeletonCurrent Opinion in Cell Biology, 1996
- Deficiency of the 50K dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophyNature, 1992
- Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrixNature, 1992